4
Total investments
0
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
May 2018
LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells.
Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail.
Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.
Experience · 5 entries
All (5)
Investments (4)
Board (4)
2019
Board Member
Apr 2019
NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The companys technology enables a wide variety of basic research and translational medicine applications.
NanoStrings products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection. In 2019, the company launched the GeoMx™ Digital Spatial Profiler enabling highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. In 2022, the company launched CosMxTM Spatial Molecular Imager, enabling the first high-plex in situ analysis platform to provide spatial multi-omics with formalin-fixed paraffin-embedded (FFPE) and fresh frozen (FF) tissue samples at cellular and subcellular resolution. CosMx SMI is a flexible, spatial single-cell imaging platform that will drive deeper insights for cell atlasing, tissue phenotyping, cell-cell interactions, cellular processes, and biomarker discovery. In 2022, AtoMx™ Spatial Informatics Platform (SIP), the only cloud-based, fully-integrated informatics platform for spatial biology, was also launched.
2018
I
Intuitive Surgical
Board Member
Aug 2018
I
Intuitive Surgical
Board Member
Aug 2018
Board Member
May 2018
LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells.
Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail.
Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.
2010
Board Member and Audit Chair
2010
Rapiscan is an industry leader in cargo and vehicle X-ray inspection, radiation detection, and optical inspection technologies. With over 50 years of industry expertise and more than 2,000 cargo and vehicle inspection systems sold in over 100 countries our broad range of cargo and vehicle scanning systems assist customers at ports, borders, military, high-threat facilities, and checkpoints to combat terrorism, drug smuggling, illegal immigration, and trade fraud. With a commitment to excellence in imaging performance, innovative design, and uncompromising quality, Rapiscan consistently delivers best-in-class imaging, high reliability, and operator satisfaction to help customers find threats and contraband with ease and confidence.
Investment activity
2018–2019 · 4 investments
Recent (last 2 years)Earlier
